چاپ صفحه |  صفحه نخست سامانه |  چکیده مقاله |  نویسندگان |  دانلود مقاله | دانشگاه علوم پزشکی تبریز |
| Abnormality in glucose transporter type 4 (GLUT‐4) function and insulin secretion are the main causes of type 2 diabetes mellitus (T2DM). Due to adverse effects of antidiabetic drugs, nowadays, nutraceuticals have been of much interest to investigators. The aim of the present study was to determine the effect of pomegranate seed oil (PSO) on the GLUT‐4 gene expression and glycemic control in obese people with T2DM. This randomized clinical trial was conducted on 52 obese type 2 diabetic patients for 8 weeks in Tabriz, Iran, in 2018. Patients were divided into the intervention group (n = 26; who consumed daily three capsules containing 1 g PSO) and the placebo group (n = 26; the same amounts paraffin). GLUT‐4 gene expression and glycemic indices were evaluated by standard methods. GLUT‐4 gene expression was increased significantly in the PSO group. Within‐group changes in fasting blood sugar (FBS) and quantitative insulin sensitivity check index were significant in the PSO group. After adjusting the age, gender, and baseline values, FBS was significantly decreased. Insulin concentration, HbA1C, HOMA‐IR, and HOMA‐β did not manifest significant changes. PSO increased the GLUT‐4 gene expression in diabetic patients without any side effects. However, future clinical studies are needed to confirm the obtained results. |
| نویسنده | نفر چندم مقاله |
|---|---|
| یاسر خواجه بیشک | اول |
| محمدرضا علی وند | سوم |
| حامد همیشه کار | چهارم |
| مجید مبصری | پنجم |
| مهدیه علیپور | هفتم |
| بیت الله علیپور | هشتم |
| نام فایل | تاریخ درج فایل | اندازه فایل | دانلود |
|---|---|---|---|
| article 3 full.pdf | 1398/04/16 | 563025 | دانلود |
| IMG-20190617-WA0000.jpg | 1398/04/16 | 29368 | دانلود |
